Clinical trial · Interventional
Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis
NCT01077882CI-TRIAL-00007346OnderHUIDscompletedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
'OnderHUIDs' is an educational program (Department of Dermatology, University Hospital, Gent) for patients with psoriasis and atopic dermatitis. We want to stimulate the patient to actively participate in their therapeutic approach by enhanced self care. We call the hypothesis that this program will help the patients learn to cope with their disease and to be loyal to their treatment, which will result in a better quality of life, better clinical outcome and cost effectiveness.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Atopic Dermatitis | — | UNRESOLVED | — |
| Psoriasis | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| education on skin disease conditions | Behavioral | — | UNRESOLVED |
| Lifestyle factors and psycho-education | Behavioral | — | UNRESOLVED |
| no educational program | Other | — | UNRESOLVED |
| Stress-reduction techniques | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- current therapy
- interventionNames
- Other: no educational program
- type
- EXPERIMENTAL
- label
- current therapy with educational program
- interventionNames
- Behavioral: education on skin disease conditions
- Behavioral: Stress-reduction techniques
- Behavioral: Lifestyle factors and psycho-education
Primary outcomes (1)
- measure
- Effectiveness of a novel educational program on the quality of life and the clinical outcome.
- timeFrame
- At 12 weeks, after 6 and 9 months
- description
- Therefore quality of life questionnaires are completed at the beginning of the program, at the end of the program (12 weeks), after 6 months and after 9 months. The quality of life questionnaires are Daily life quality index, Skindex 29, EuroQol -5D, Short Form - 36 , Psoriasis disability index, Quality of Life Index for Atopic Dermatitis. The clinical effectiveness is determined by measuring psoriasis area and severity index (PASI) or scoring atopic dermatitis (SCORAD) at the beginning of the program, at the end of the program (12 weeks), after 6 months and after 9 months.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who have given written informed consent * Women or men of any race * Patients who are 18-75 years of age * Diagnosis of psoriasis or atopic dermatitis Exclusion Criteria: * Patients with a cognitive disorder (not able to understand, speak, read or write..) * Patients with a significant underlying medical cause (i.e. severe infection, haematologic disease, malignity, severe renal or hepatic disease, major depression) in the last 3 months * Patients under experimental pharmaceutical medication
References
Publications (0)
Data not yet available
No reference posted for this study.